Kiani Adnan N, Magder Laurence S, Post Wendy S, Szklo Moyses, Bathon Joan M, Schreiner Pam J, O'Leary Daniel, Petri Michelle
Department of Medicine, Division of Rheumatology, Johns Hopkins University.
Department of Epidemiology and Preventive Medicine, University of Maryland.
Rheumatology (Oxford). 2015 Nov;54(11):1976-81. doi: 10.1093/rheumatology/kev198. Epub 2015 Jun 22.
Accelerated atherosclerosis is a major cause of morbidity and death in SLE. The purpose of this study was to determine whether the prevalence and extent of coronary artery calcium (CAC) is higher in female SLE patients compared with a non-SLE sample from the Multi-Ethnic Study of Atherosclerosis (MESA).
CAC was measured in 80 female SLE patients and 241 female MESA controls from the Baltimore Field Centre, ages 45-64 years, without evidence of clinical cardiovascular disease. Binary regression was used to estimate the ratio of CAC prevalence in SLE vs MESA controls, controlling for demographic and cardiovascular risk factors. To compare the groups with respect to the quantity of CAC among those with non-zero Agatston scores, we used linear models in which the outcome was a log-transformed Agatston score.
The prevalence of CAC was substantially higher in SLE. The differences were most pronounced and statistically significant in those aged 45-54 years (58% vs 20%, P < 0.0001), but were still observed among those aged 55-65 years (57% vs 36%, P = 0.069). After controlling for age, ethnicity, education, income, diabetes mellitus, hypertension, hyperlipidaemia, high-density lipoprotein levels, smoking, education and BMI, SLE patients still had a significantly higher prevalence of CAC than controls. Among those with CAC, the mean log Agatston score did not differ significantly between SLE and MESA participants.
Women with SLE have a higher prevalence of CAC than comparable women without SLE, even after adjusting for traditional cardiovascular risk factors, especially among those aged 45-54 years.
动脉粥样硬化加速是系统性红斑狼疮(SLE)发病和死亡的主要原因。本研究的目的是确定与动脉粥样硬化多民族研究(MESA)中的非SLE样本相比,女性SLE患者冠状动脉钙化(CAC)的患病率和程度是否更高。
对来自巴尔的摩现场中心的80名年龄在45 - 64岁、无临床心血管疾病证据的女性SLE患者和241名女性MESA对照者进行了CAC测量。采用二元回归估计SLE与MESA对照者中CAC患病率的比值,并对人口统计学和心血管危险因素进行控制。为了比较非零阿加斯顿评分者中两组的CAC数量,我们使用了线性模型,其中结果是对数转换后的阿加斯顿评分。
SLE患者中CAC的患病率显著更高。在45 - 54岁的人群中差异最为明显且具有统计学意义(58%对20%,P < 0.0001),但在55 - 65岁的人群中也有观察到差异(57%对36%,P = 0.069)。在控制了年龄、种族、教育程度、收入、糖尿病、高血压、高脂血症、高密度脂蛋白水平、吸烟、教育程度和体重指数后,SLE患者的CAC患病率仍显著高于对照组。在患有CAC的人群中,SLE患者和MESA参与者的平均对数阿加斯顿评分没有显著差异。
即使在调整了传统心血管危险因素后,患有SLE的女性比没有SLE的可比女性患CAC的患病率更高,尤其是在45 - 54岁的人群中。